Ruling Against Hi-Tech Pharmaceuticals Spotlights FTC Strategies
This article was originally published in The Tan Sheet
Executive Summary
A recent court ruling emphasizes Federal Trade Commission strategies to prevent companies from repeatedly making false claims, stretching substantiation data, using deceptive endorsements and creating shell businesses